ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,108Medicare Part D Prescriptions Filled, Including Refills

Rank: 71 out of 1844

$781K Total Retail Price of All Prescriptions

Rank: 110 out of 1844

462 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 462 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 462 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 13,039 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 481 432 1 1
AMLODIPINE BESYLATE 446 410 2 6
LISINOPRIL 437 416 3 4
FUROSEMIDE 400 362 4 7
OMEPRAZOLE 378 298 5 5
HYDROCODONE-ACETAMINOPHEN 351 278 S3 6 2
SIMVASTATIN 348 342 7 3
PRAVASTATIN SODIUM 330 308 8 10
ATORVASTATIN CALCIUM 293 257 9 12
WARFARIN SODIUM 290 229 10 13
DONEPEZIL HCL 279 279 11 26
POTASSIUM CHLORIDE 269 243 12 16
METOPROLOL TARTRATE 243 214 13 11
METFORMIN HCL 239 223 14 8
NAMENDA 238 233 15 33
MIRTAZAPINE 230 200 16 49
PREDNISONE 221 169 17 40
CITALOPRAM HBR 214 164 18 19
METOPROLOL SUCCINATE 180 167 19 14
PANTOPRAZOLE SODIUM 161 146 20 32
GLIMEPIRIDE 159 131 21 35
ESCITALOPRAM OXALATE 157 142 22 52
ISOSORBIDE MONONITRATE ER 149 149 23 59
GABAPENTIN 142 142 24 15
MELOXICAM 141 126 25 28
TRAMADOL HCL 137 127 26 18
TRAZODONE HCL 136 131 27 43
ATENOLOL 132 104 28 17
FENOFIBRATE 131 116 29 71
CARVEDILOL 128 127 30 22
VENLAFAXINE HCL ER 123 121 31 93
ALENDRONATE SODIUM 121 108 32 25
METFORMIN HCL ER 110 88 33 46
ALLOPURINOL 107 97 34 29
COMBIVENT 99 64 35 131
CLOPIDOGREL 99 97 35 34
AMITRIPTYLINE HCL 98 36 R 37 72
SULFAMETHOXAZOLE-TRIMETHOPRIM 97 91 38 73
TAMSULOSIN HCL 96 89 39 27
SERTRALINE HCL 95 61 40 21
LOSARTAN POTASSIUM 94 87 41 24
HYDROCHLOROTHIAZIDE 93 93 42 9
NITROGLYCERIN PATCH 90 84 43 173
FENTANYL 89 61 S2 44 66
POLYETHYLENE GLYCOL 3350 89 58 44 39
ZOLPIDEM TARTRATE 89 67 44 23
LOSARTAN-HYDROCHLOROTHIAZIDE 83 56 47 47
ENALAPRIL MALEATE 83 83 47 69
NYSTATIN 82 79 49 85
LIPITOR 79 70 50 159
DOXYCYCLINE HYCLATE 78 62 51 90
TRIAMTERENE-HCTZ 78 75 51 48
OXYBUTYNIN CHLORIDE 77 62 53 103
LANTUS 77 77 53 42
PLAVIX 76 73 55 61
DIGOXIN 70 68 56 67
DIVALPROEX SODIUM 66 65 57 74
RANITIDINE HCL 65 65 58 38
SPIRONOLACTONE 64 42 59 60
QUINAPRIL HCL 63 63 60 152
LEVOFLOXACIN 62 52 61 78
CRESTOR 62 43 61 30
TAMIFLU 60 60 63 296
RISPERIDONE 60 60 63 65
VERAPAMIL ER 59 59 65 98
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 56 66 20
PAROXETINE HCL 57 49 67 68
CIPROFLOXACIN HCL 57 49 67 62
BENAZEPRIL HCL 56 40 69 75
DILANTIN 56 24 69 287
CYCLOBENZAPRINE HCL 56 46 R 69 53
LOVASTATIN 55 51 72 44
CLARITHROMYCIN 55 47 72 339
BENICAR 54 47 74 218
CEPHALEXIN 54 46 74 56
LANSOPRAZOLE 52 47 76 194
ONDANSETRON HCL 51 35 77 267
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.